Five UAB School of Medicine faculty projects were recently funded through an AMC21 initiative, giving NIH-funded investigators incentive to submit a second R01. The projects, chosen based on scientific merit, were eligible for $50,000 per year for a project period of up to two years, pending appropriate progress and achieving benchmarks. The goal is to have a new funded R01 by the second year. Trent Tipple, M.D., Neonatology, received funding for his project titled, “Harnessing the Anti-inflammatory and Antibacterial Effects of Thioredoxin Reductase-1 Inhibition to Treat Acute Lung Injury.” Dr. Tipple Receives Funding Through an AMC21 Initiative
Five UAB School of Medicine faculty projects were recently funded through an AMC21 initiative, giving NIH-funded investigators incentive to submit a second R01. The projects, chosen based on scientific merit, were eligible for $50,000 per year for a project period of up to two years, pending appropriate progress and achieving benchmarks. The goal is to have a new funded R01 by the second year. Trent Tipple, M.D., Neonatology, received funding for his project titled, “Harnessing the Anti-inflammatory and Antibacterial Effects of Thioredoxin Reductase-1 Inhibition to Treat Acute Lung Injury.”